RecruitingNot ApplicableNCT06717048

Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

An Exploratory Study on the Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

Sponsor

Shanghai Eye Disease Prevention and Treatment Center

Enrollment

108 participants

Start Date

Dec 9, 2024

Study Type

INTERVENTIONAL

Conditions

Myopia Choroidal thickness Refractive Error - Myopia Retina

Summary

To explore the minimum power and frequency of Repeated Low-level Red-light (RLRL) to control myopia progression in low-myopic children aged 8-10 years, and the rebound effect of low-myopic children after discontinuation of RLRL with different combinations of power and frequency.

Eligibility

Min Age: 8 YearsMax Age: 10 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Red LED and a medical device called Repeated Low-level Red-light for people with choroidal thickness, myopia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 8 Years to 10 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERepeated Low-level Red-light

In addition to single vision spectacle lenses (SVS) with power for correcting distance refraction, the subjects used the prescribed power low-intensity red light treatment instrument for the prescribed number of treatments from Monday to Friday, with a 3-minute interval of 4 hours.

DEVICERed LED

In addition to SVS with power for correcting distance refraction, red LED will be performed twice per school day with an interval of at least 4 hours, each treatment last 3 minutes.